Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
gptkb:H02AB02
|
| gptkbp:CASNumber |
gptkb:50-02-2
|
| gptkbp:chemicalFormula |
C22H29FO5
|
| gptkbp:contraindication |
systemic fungal infection
|
| gptkbp:drugClass |
gptkb:Corticosteroid
|
| gptkbp:eliminatedIn |
urine
|
| gptkbp:FDAApproved |
yes
|
| gptkbp:genericName |
gptkb:dexamethasone
|
| gptkbp:halfLife |
36-54 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Decadron
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous |
| gptkbp:sideEffect |
high blood pressure
mood changes weight gain insomnia increased appetite hyperglycemia |
| gptkbp:usedFor |
autoimmune disorders
inflammation allergic reactions adrenal insufficiency certain cancers |
| gptkbp:bfsParent |
gptkb:dexamethasone
|
| gptkbp:bfsLayer |
5
|